Frontiers in Pharmacology
Scope & Guideline
Advancing pharmacological frontiers for a healthier tomorrow.
Introduction
Aims and Scopes
- Pharmacological Mechanisms and Drug Action:
The journal emphasizes research that elucidates the mechanisms of drug action at molecular, cellular, and systemic levels, contributing to the understanding of how drugs interact with biological systems. - Clinical Pharmacology and Therapeutics:
Publications often focus on the clinical application of pharmacological principles, including studies on drug efficacy, safety, and the pharmacokinetics and pharmacodynamics of various therapeutic agents. - Natural Products and Traditional Medicine:
There is a strong interest in exploring natural compounds and traditional herbal medicines, investigating their pharmacological effects, mechanisms of action, and potential therapeutic applications. - Pharmacogenomics and Personalized Medicine:
Research on genetic variations affecting drug metabolism and response is a significant area, promoting the development of personalized medicine approaches to optimize drug therapies. - Drug Safety and Pharmacovigilance:
The journal covers studies related to drug safety, adverse effects, and pharmacovigilance, highlighting the importance of monitoring and evaluating drug-related outcomes in clinical settings. - Innovative Drug Delivery Systems:
Research on novel drug delivery technologies, including nanoparticles and other advanced formulations, is also featured, aiming to enhance drug efficacy and reduce side effects.
Trending and Emerging
- Integrated Omics Approaches:
There is a significant rise in studies employing integrated omics methodologies (genomics, proteomics, metabolomics) to understand drug mechanisms and disease pathology, reflecting a trend towards holistic research perspectives. - Targeting the Gut Microbiome:
Research focusing on the gut microbiome's role in drug metabolism, efficacy, and disease treatment is gaining traction, highlighting its importance in personalized medicine and therapeutic outcomes. - Emerging Therapeutics and Drug Repurposing:
The journal is increasingly publishing articles on the repurposing of existing drugs for new therapeutic uses, emphasizing the potential of known compounds in treating various diseases. - Nanotechnology in Drug Delivery:
The application of nanotechnology for drug delivery systems is a rapidly growing area, with numerous studies investigating how nanoparticles can enhance the efficacy and safety of therapeutic agents. - Pharmacogenomics and Precision Medicine:
The focus on pharmacogenomics is expanding, with more research dedicated to understanding genetic influences on drug response, which is crucial for developing precision medicine strategies. - Natural Products as Therapeutic Agents:
A resurgence in interest for natural products, including herbal medicines and their bioactive components, is evident, particularly in their roles as potential candidates for innovative therapies.
Declining or Waning
- Conventional Pharmacological Approaches:
There has been a noticeable shift from traditional pharmacological studies towards more integrative and innovative methodologies, including systems biology and multi-omics approaches, reflecting a decline in purely conventional pharmacology research. - Single-Agent Drug Studies:
Research focusing solely on the effects of single-agent drugs is becoming less common, as there is a growing preference for studies that explore combination therapies and polypharmacology to address complex diseases. - Basic Pharmacology without Clinical Relevance:
Papers that do not bridge basic pharmacology with clinical applications are less frequently accepted, indicating a trend towards research that has direct implications for therapeutic practices. - Static Drug Interaction Studies:
The field is moving away from static studies of drug interactions to more dynamic models that incorporate patient-specific factors, highlighting a decline in traditional drug interaction research.
Similar Journals
DARU-Journal of Pharmaceutical Sciences
Advancing pharmaceutical knowledge for a healthier tomorrow.DARU-Journal of Pharmaceutical Sciences is a leading peer-reviewed journal published by SPRINGER INT PUBL AG that focuses on the dynamic and rapidly evolving fields of pharmaceutical sciences, including drug discovery, pharmacology, and toxicology. With an impressive Q2 ranking in both Drug Discovery and Miscellaneous Medicine categories for 2023, this journal stands out as a vital resource for researchers, professionals, and students alike, offering a platform for significant contributions to the scientific community. Covering a comprehensive scope from 2000 to 2024 and indexed by Scopus, the journal ranks within the top percentile in its field, with a ranking of #66/313 in Pharmacology and #34/157 in Drug Discovery, reaffirming its impact and relevance. The journal promotes open access to foster widespread dissemination of knowledge in pharmaceutical sciences, ultimately aiming to bridge the gap between research and clinical applications. For those looking to stay at the forefront of pharmaceutical innovation, DARU represents an invaluable connection to the latest studies and breakthrough findings.
DRUG DEVELOPMENT RESEARCH
Advancing pharmaceutical innovation through rigorous research.DRUG DEVELOPMENT RESEARCH is a premier interdisciplinary journal published by Wiley, focusing on the latest advancements in drug discovery, pharmacology, and toxicology. With an ISSN of 0272-4391 and an E-ISSN of 1098-2299, this esteemed publication has been a cornerstone in the field since its inception in 1981 and continues to provide cutting-edge research until 2024. Its rigorous peer-review process and strategic placement in Q2 of the Drug Discovery category, as well as ranking #60 out of 157 in Scopus, underscore the journal's relevance and influence, boasting a respectable 62nd percentile ranking. While the journal does not currently offer open access, it remains a vital resource for researchers, professionals, and students seeking to expand their knowledge on the processes of drug development, identifying new therapeutic targets, and assessing the efficacy and safety of novel compounds. Situated in Hoboken, NJ, this journal stands at the forefront of pharmaceutical innovation, making significant contributions to the advancement of medical science.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
Elevating clinical practice with evidence-based insights.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, published by DUSTRI-VERLAG DR KARL FEISTLE in Germany, is a vital scholarly platform dedicated to advancing the field of pharmacology through rigorous research and innovative therapeutic strategies. Established in 1994, this journal has maintained its relevance in the evolving landscape of clinical pharmacology, achieving a Q3 rank in both general and medical pharmacology categories as of 2023. With an ISSN of 0946-1965, it is positioned as an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of drug therapy and pharmacological applications. Though it currently does not offer open access, its comprehensive scope covers a wide array of topics within pharmacology, promising to contribute significantly to scientific discussions and knowledge dissemination from 1994 to 2024. Whether you are looking for the latest studies or historical insights, the journal remains a fixture for anyone invested in the pharmacological sciences.
Drug Design Development and Therapy
Transforming Pharmaceutical Science with Cutting-Edge InsightsDrug Design Development and Therapy is a premier open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of drug discovery, pharmaceutical science, and pharmacology. With an impressive Q1 ranking in its categories as of 2023, this journal is recognized for its significant contributions to the understanding of drug design and therapeutic innovations, making it an invaluable resource for researchers, professionals, and students alike. Established in 2007 and committed to open-access since 2008, the journal provides an inclusive platform for disseminating high-quality research from around the globe. With a robust impact factor and remarkable Scopus rankings, including a 24th place in Pharmaceutical Science and a 48th place in Pharmacology, it reflects a strong percentile performance, ensuring that published articles reach and impact a wide audience. By fostering the exchange of cutting-edge information on drug development and delivery systems, Drug Design Development and Therapy continues to play a crucial role in the ongoing battle against disease, promoting innovative approaches to therapeutic solutions and enhancing patient care.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Pioneering Research in Pharmacology Since 1969NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY is a prestigious journal published by SPRINGER, focusing on the dynamic fields of pharmacology and toxicology. With an ISSN of 0028-1298 and an E-ISSN of 1432-1912, this esteemed publication has been a staple in the scientific community since its inception in 1969, continuing to wield influence with a convergence of research that reaches through 2024. Ranked in the Q2 category for both medicine and pharmacology, it stands at an impressive 111th out of 313 in the Scopus rankings for pharmacology, reflecting its significant impact in the field. Though not offering open access, the journal remains a vital resource for researchers, professionals, and students seeking to explore groundbreaking studies and advancements in pharmacological science. With its high standards and comprehensive coverage, NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY is essential reading for those dedicated to understanding the mechanisms of drug action and the complexities of therapeutic interventions.
ACTA PHARMACOLOGICA SINICA
Connecting Global Minds in PharmacologyACTA PHARMACOLOGICA SINICA is a premier journal in the field of pharmacology, published by the esteemed Nature Publishing Group. With a strong history since its inception in 1980, this journal is recognized for its impactful contributions to the fields of medicine and pharmacology, consistently securing a Q1 ranking in multiple relevant categories, including Pharmacology (Medical). Drawing on a robust international readership, it ranks impressively at #8 out of 272 in the specialty of Medical Pharmacology, placing it in the top 97th percentile according to Scopus data. Although currently not an open-access publication, ACTA PHARMACOLOGICA SINICA remains a vital resource for researchers, professionals, and students seeking to advance their understanding of pharmacological sciences. Its commitment to disseminating high-quality research underscores its significance in fostering innovation and exploration in the medical landscape.
FUNDAMENTAL & CLINICAL PHARMACOLOGY
Exploring the intersection of fundamental research and clinical application.FUNDAMENTAL & CLINICAL PHARMACOLOGY is a distinguished journal dedicated to advancing the fields of pharmacology and clinical medicine. Published by WILEY, this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike to disseminate innovative research findings and clinical applications. With an impressive history spanning from 1987 to 2024, it has consistently maintained its relevance in the scientific community, evidenced by its Q2 quartile ranking in both Pharmacology and Pharmacology (medical) categories for 2023. The journal's diverse publication range, which includes original research articles, reviews, and clinical studies, helps bridge the gap between fundamental research and practical application in healthcare settings. Although it does not offer open access, its rigorous peer-review process ensures that published content meets the highest scholarly standards, making it a vital resource for those aiming to stay at the forefront of pharmacological sciences.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
Pioneering research at the intersection of science and care.Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Unlocking the Secrets of Drug Action and EfficacyThe JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, published by the American Society for Pharmacology and Experimental Therapeutics, stands as a pivotal platform in the fields of pharmacology and molecular medicine. With an impressive convergence of knowledge from 1945 to 2024, this esteemed journal is recognized for its rigorous peer-reviewed research, contributing significantly to our understanding of drug action and therapeutic interventions. It holds a commendable position in the Q2 quartile in both Molecular Medicine and Pharmacology, emphasizing its relevance and impact within the contemporary scientific landscape, as evidenced by its Scopus ranking that places it amongst the leading journals in its category. Aimed at researchers, professionals, and students, the journal not only fosters a deeper insight into toxicology, pharmacodynamics, and therapeutic strategies but also encourages innovation through its comprehensive access to groundbreaking experimental methodologies. The journal continues to foster discourse and disseminate research that shapes the future of pharmacological science.
INDIAN JOURNAL OF PHARMACOLOGY
Empowering researchers with cutting-edge pharmacological discoveries.INDIAN JOURNAL OF PHARMACOLOGY, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the field of pharmacology and its related disciplines. With a rich history since its inception in 1978, this journal aims to disseminate high-quality research findings, reviews, and clinical studies that contribute to the global understanding of drug action and therapeutic practices. As a valuable resource for researchers, professionals, and students alike, it operates within the Q3 quartile of the Pharmacology category, positioning itself as an influential contributor in the realm of medical pharmacology. The journal is committed to publishing rigorous scientific inquiry, fostering innovation, and bridging gaps between laboratory research and clinical application. Readers can access its wide-ranging articles to stay informed about the latest advancements in the field, reflecting its crucial role in shaping future pharmacological research and practice.